Healthcare -
Biotechnology - NASDAQ - US
$ 5.36
2.68 %
$ 1.28 B
Market Cap
-31.53
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ardelyx, Inc.
| Net Income | -39.1 M |
| Depreciation & Amortization | 2.06 M |
| Capital Expenditures | -1.01 M |
| Stock-Based Compensation | 37.4 M |
| Change in Working Capital | 0 |
| Others | -45.1 M |
| Free Cash Flow | -45.8 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (39.1) | (66.1) | (67.2) | (158.2) | (94.3) | (94.9) | (91.3) | (64.3) | (112.4) | (29.6) | (3.2) | (6.6) | (9.8) |
| Depreciation & Amortization | 2.1 | 1.3 | 1.1 | 1.4 | 1.8 | 2.5 | 2.7 | 2.6 | 1.3 | 0.8 | 0.3 | 0.6 | 0.7 |
| Deferred Income Tax | 0 | 0 | 0 | (0.2) | 0.3 | (0.3) | (1.0) | 11 K | 86 K | 65 K | 0 | 0 | 0 |
| Stock Based Compensation | 37.4 | 13.5 | 10.8 | 12.0 | 10.6 | 9.9 | 9.2 | 9.6 | 5.3 | 2.6 | 1.7 | 0.4 | 0.5 |
| Other Operating Activities | (45.1) | 4.9 | 4.8 | 4.2 | 3.4 | 3.3 | 0.8 | 0.6 | 0.5 | 0.5 | 1.6 | 3.5 | 0.9 |
| Change in Working Capital | 0 | (43.4) | (19.6) | (11.9) | (3.2) | 3.0 | 9.4 | (13.7) | 12.8 | (46.2) | 13.0 | 3.9 | 29.7 |
| Cash From Operations | (44.8) | (89.7) | (70.0) | (152.6) | (81.4) | (76.5) | (70.3) | (65.2) | (92.5) | (71.8) | 13.4 | 1.8 | 22.0 |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (1.0) | (0.3) | 55 K | (1.9) | (0.3) | (0.3) | (0.3) | (2.4) | (4.9) | (3.5) | (1.9) | (0.3) | (0.1) |
| Other Items | (17.3) | (130.9) | 18.5 | 52.8 | (31.1) | 23.7 | (29.6) | 67.6 | (126.2) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (18.3) | (131.2) | 18.4 | 50.9 | (31.4) | 23.4 | (29.9) | 65.3 | (131.1) | (3.5) | (1.9) | (0.3) | (0.1) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 8.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 K | 2 K | 20 K |
| Total Debt Repaid | 0 | 22.4 | (6.1) | (19.4) | (0.1) | 0 | 49.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 106.6 | 4.7 | 9.8 | 1.3 | 1.9 | 0.6 | 0.5 | 0.7 | 0.6 | 0.7 | 69 K | 1 K | 0.3 |
| Cash From Financing Activities | 106.6 | 146.3 | 75.3 | 83.0 | 22.8 | 155.5 | 103.6 | 0.7 | 191.2 | 75.0 | 61.3 | 1 K | 0.3 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 43.5 | (74.7) | 23.7 | (18.6) | (90.1) | 102.4 | 3.4 | 0.8 | (32.4) | (0.3) | 72.9 | 1.5 | 22.1 |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (45.8) | (90.1) | (70.1) | (154.4) | (81.8) | (76.8) | (70.6) | (67.5) | (97.4) | (75.3) | 11.5 | 1.5 | 21.9 |